{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:11:41Z","timestamp":1778555501988,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T00:00:00Z","timestamp":1445558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T00:00:00Z","timestamp":1445558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1038\/cgt.2015.50","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T10:27:55Z","timestamp":1445596075000},"page":"573-580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["RETRACTED ARTICLE: Functional studies of miR-130a on the inhibitory pathways of apoptosis in patients with chronic myeloid leukemia"],"prefix":"10.1038","volume":"22","author":[{"given":"X","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,23]]},"reference":[{"key":"BFcgt201550_CR1","doi-asserted-by":"publisher","first-page":"e105200","DOI":"10.1371\/journal.pone.0105200","volume":"9","author":"J Cai","year":"2014","unstructured":"Cai J, Wu G, Tan X, Han Y, Chen C, Li C et al. Transferred BCR\/ABL DNA from K562 extracellular vesicles causes chronic myeloid leukemia in immunodeficient mice. PLoS One 2014; 9: e105200.","journal-title":"PLoS One"},{"key":"BFcgt201550_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.gene.2014.03.049","volume":"542","author":"D Joshi","year":"2014","unstructured":"Joshi D, Chandrakala S, Korgaonkar S, Ghosh K, Vundinti BR . Down-regulation of miR-199b associated with imatinib drug resistance in 9q34.1 deleted BCR\/ABL positive CML patients. Gene 2014; 542: 109\u2013112.","journal-title":"Gene"},{"key":"BFcgt201550_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/cas.12339","volume":"105","author":"C Nishioka","year":"2014","unstructured":"Nishioka C, Ikezoe T, Yang J, Nobumoto A, Tsuda M, Yokoyama A . Downregulation of miR-217 correlates with resistance of Ph(+) leukemia cells to ABL tyrosine kinase inhibitors. Cancer Sci 2014; 105: 297\u2013307.","journal-title":"Cancer Sci"},{"key":"BFcgt201550_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.exphem.2013.11.006","volume":"42","author":"EG Karimiani","year":"2014","unstructured":"Karimiani EG, Marriage F, Merritt AJ, Burthem J, Byers RJ, Day PJ . Single-cell analysis of K562 cells: an imatinib-resistant subpopulation is adherent and has upregulated expression of BCR-ABL mRNA and protein. Exp Hematol 2014; 42: 183\u2013191, e5.","journal-title":"Exp Hematol"},{"key":"BFcgt201550_CR5","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.leukres.2013.07.019","volume":"37","author":"T Shibuta","year":"2013","unstructured":"Shibuta T, Honda E, Shiotsu H, Tanaka Y, Vellasamy S, Shiratsuchi M et al. Imatinib induces demethylation of miR-203 gene: an epigenetic mechanism of anti-tumor effect of imatinib. Leuk Res 2013; 37: 1278\u20131286.","journal-title":"Leuk Res"},{"key":"BFcgt201550_CR6","first-page":"276","volume":"65","author":"N Hamerschlak","year":"2014","unstructured":"Hamerschlak N, Souza CD, Cornacchioni AL, Pasquini R, Tabak D, Spector N et al. Patients' perceptions about diagnosis and treatment of chronic myeloid leukemia: a cross-sectional study among Brazilian patients. Sao Paulo Med J 2014; 65: 276\u2013283.","journal-title":"Sao Paulo Med J"},{"key":"BFcgt201550_CR7","doi-asserted-by":"publisher","first-page":"9650","DOI":"10.18632\/oncotarget.2520","volume":"5","author":"C Eichelser","year":"2014","unstructured":"Eichelser C, St\u00fcckrath I, M\u00fcller V, Milde-Langosch K, Wikman H, Pantel K et al. Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients. Oncotarget 2014; 5: 9650\u20139663.","journal-title":"Oncotarget"},{"key":"BFcgt201550_CR8","doi-asserted-by":"publisher","first-page":"e79173","DOI":"10.1371\/journal.pone.0079173","volume":"8","author":"M Zhang","year":"2013","unstructured":"Zhang M, Luo W, Huang B, Liu Z, Sun L, Zhang Q et al. Overexpression of JAM-A in non-small cell lung cancer correlates with tumor progression. PLoS One 2013; 8: e79173.","journal-title":"PLoS One"},{"key":"BFcgt201550_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/cgt.2014.44","volume":"21","author":"Z Xishan","year":"2014","unstructured":"Xishan Z, Xianjun L, Ziying L, Guangxin C, Gang L . The malignancy suppression role of miR-23a by targeting the BCR\/ABL oncogene in chromic myeloid leukemia. Cancer Gene Ther 2014; 21: 397\u2013404.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201550_CR10","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.3892\/or.2014.3118","volume":"31","author":"J Zhang","year":"2014","unstructured":"Zhang J, Wang P, Zhu J, Wang W, Yin J, Zhang C et al. SPARC expression is negatively correlated with clinicopathological factors of gastric cancer and inhibits malignancy of gastric cancer cells. Oncol Rep 2014; 31: 2312\u20132320.","journal-title":"Oncol Rep"},{"key":"BFcgt201550_CR11","doi-asserted-by":"publisher","first-page":"582140","DOI":"10.1155\/2014\/582140","volume":"2014","author":"L Bubnovskaya","year":"2014","unstructured":"Bubnovskaya L, Kovelskaya A, Gumenyuk L, Ganusevich I, Mamontova L, Mikhailenko V et al. Disseminated tumor cells in bone marrow of gastric cancer patients: correlation with tumor hypoxia and clinical relevance. J Oncol 2014; 2014: 582140.","journal-title":"J Oncol"},{"key":"BFcgt201550_CR12","doi-asserted-by":"publisher","first-page":"9118","DOI":"10.18632\/oncotarget.2361","volume":"5","author":"X Chen","year":"2014","unstructured":"Chen X, Shi X, Zhao C, Li X, Lan X, Liu S et al. Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr\/Abl-dependent and -independent mechanisms. Oncotarget 2014; 5: 9118\u20139132.","journal-title":"Oncotarget"},{"key":"BFcgt201550_CR13","first-page":"970","volume":"55","author":"M Shibazaki","year":"2014","unstructured":"Shibazaki M, Sumi M, Takeda W, Kirihara T, Kurihara T, Sato K et al. Therapy-related chronic myelogenous leukemia following RFM therapy in a patient with follicular lymphoma. Rinsho Ketsueki 2014; 55: 970\u2013974.","journal-title":"Rinsho Ketsueki"},{"key":"BFcgt201550_CR14","first-page":"2795","volume":"127","author":"S Wei","year":"2014","unstructured":"Wei S, Wang Y, Chai Q, Fang Q, Zhang Y, Lu Y et al. Over-expression of heme oxygenase-1 in peripheral blood predicts the progression and relapse risk of chronic myeloid leukemia. Chin Med J (Engl) 2014; 127: 2795\u20132801.","journal-title":"Chin Med J (Engl)"},{"key":"BFcgt201550_CR15","doi-asserted-by":"publisher","first-page":"e105200","DOI":"10.1371\/journal.pone.0105200","volume":"9","author":"J Cai","year":"2014","unstructured":"Cai J, Wu G, Tan X, Han Y, Chen C, Li C et al. Transferred BCR\/ABL DNA from K562 extracellular vesicles causes chronic myeloid leukemia in immunodeficient mice. PLoS One 2014; 9: e105200.","journal-title":"PLoS One"},{"key":"BFcgt201550_CR16","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1016\/j.bmcl.2014.07.069","volume":"24","author":"R Rondanin","year":"2014","unstructured":"Rondanin R, Simoni D, Romagnoli R, Baruchello R, Marchetti P, Costantini C et al. Inhibition of activated STAT5 in Bcr\/Abl expressing leukemia cells with new pimozide derivatives. Bioorg Med Chem Lett 2014; 24: 4568\u20134574.","journal-title":"Bioorg Med Chem Lett"},{"key":"BFcgt201550_CR17","doi-asserted-by":"publisher","first-page":"e61858","DOI":"10.1371\/journal.pone.0061858","volume":"8","author":"Y Li","year":"2013","unstructured":"Li Y, Yuan Y, Tao K, Wang X, Xiao Q, Huang Z et al. Inhibition of BCR\/ABL protein expression by miR-203 sensitizes for imatinib mesylate. PLoS One 2013; 8: e61858.","journal-title":"PLoS One"},{"key":"BFcgt201550_CR18","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.yexcr.2013.02.002","volume":"319","author":"Y Li","year":"2013","unstructured":"Li Y, Wang H, Tao K, Xiao Q, Huang Z, Zhong L et al. miR-29b suppresses CML cell proliferation and induces apoptosis via regulation of BCR\/ABL1 protein. Exp Cell Res 2013; 319: 1094\u20131101.","journal-title":"Exp Cell Res"},{"key":"BFcgt201550_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1039\/c3ib20230e","volume":"5","author":"M Verma","year":"2013","unstructured":"Verma M, Karimiani EG, Byers RJ, Rehman S, Westerhoff HV, Day PJ . Mathematical modelling of miRNA mediated BCR.ABL protein regulation in chronic myeloid leukaemia vis-a-vis therapeutic strategies. Integr Biol (Camb) 2013; 5: 543\u2013554.","journal-title":"Integr Biol (Camb)"},{"key":"BFcgt201550_CR20","first-page":"607","volume":"58","author":"Z Xishan","year":"2012","unstructured":"Xishan Z, Xu Z, Lawei Y, Gang L . Hemangioblastic characteristics of cancer stem cells in chronic myeloid leukemia. Clin Lab 2012; 58: 607\u2013613.","journal-title":"Clin Lab"},{"key":"BFcgt201550_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.leukres.2012.12.003","volume":"37","author":"Y Liu","year":"2013","unstructured":"Liu Y, Song Y, Ma W, Zheng W, Yin H . Decreased microRNA-30a levels are associated with enhanced ABL1 and BCR-ABL1 expression in chronic myeloid leukemia. Leuk Res 2013; 37: 349\u2013356.","journal-title":"Leuk Res"},{"key":"BFcgt201550_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/onc.2012.557","volume":"33","author":"C Xu","year":"2014","unstructured":"Xu C, Fu H, Gao L, Wang L, Wang W, Li J et al. BCR-ABL\/GATA1\/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia. Oncogene 2014; 33: 44\u201354.","journal-title":"Oncogene"},{"key":"BFcgt201550_CR23","doi-asserted-by":"publisher","first-page":"e32834","DOI":"10.1371\/journal.pone.0032834","volume":"7","author":"J Fei","year":"2012","unstructured":"Fei J, Li Y, Zhu X, Luo X . miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML). PLoS One 2012; 7: e32834.","journal-title":"PLoS One"},{"key":"BFcgt201550_CR24","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.leukres.2011.03.029","volume":"35","author":"T Lopotov\u00e1","year":"2011","unstructured":"Lopotov\u00e1 T, Z\u00e1\u010dkov\u00e1 M, Klamov\u00e1 H, Moravcov\u00e1 J . MicroRNA-451 in chronic myeloid leukemia: miR-451-BCR-ABL regulatory loop? Leuk Res 2011; 35: 974\u2013977.","journal-title":"Leuk Res"},{"key":"BFcgt201550_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11899-011-0085-y","volume":"6","author":"F Pellicano","year":"2011","unstructured":"Pellicano F, Sinclair A, Holyoake TL . In search of CML stem cells' deadly weakness. Curr Hematol Malig Rep 2011; 6: 82\u201387.","journal-title":"Curr Hematol Malig Rep"},{"key":"BFcgt201550_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3109\/10428194.2010.546914","volume":"52","author":"D Perrotti","year":"2011","unstructured":"Perrotti D, Harb JG . BCR-ABL1 kinase-dependent alteration of mRNA metabolism: potential alternatives for therapeutic intervention. Leuk Lymphoma 2011; 52: 30\u201344.","journal-title":"Leuk Lymphoma"},{"key":"BFcgt201550_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00277-010-1072-4","volume":"90","author":"K Hussein","year":"2011","unstructured":"Hussein K, B\u00fcsche G, Muth M, G\u00f6hring G, Kreipe H, Bock O . Expression of myelopoiesis-associated microRNA in bone marrow cells of atypical chronic myeloid leukaemia and chronic myelomonocytic leukaemia. Ann Hematol 2011; 90: 307\u2013313.","journal-title":"Ann Hematol"},{"key":"BFcgt201550_CR28","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.cell.2010.01.007","volume":"140","author":"AM Eiring","year":"2010","unstructured":"Eiring AM, Harb JG, Neviani P, Garton C, Oaks JJ, Spizzo R et al. miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 2010; 140: 652\u2013665.","journal-title":"Cell"},{"key":"BFcgt201550_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00277-012-1591-2","volume":"92","author":"M Tiribelli","year":"2013","unstructured":"Tiribelli M, Latagliata R, Luciano L, Castagnetti F, Gozzini A, Cambrin GR et al. Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia. Ann Hematol 2013; 92: 179\u2013183.","journal-title":"Ann Hematol"},{"key":"BFcgt201550_CR30","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/nar\/gki200","volume":"33","author":"AM Cheng","year":"2005","unstructured":"Cheng A M, Byrom MW, Shelton J, Ford LP . Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 2005; 33: 1290\u20131297.","journal-title":"Nucleic Acids Res"},{"key":"BFcgt201550_CR31","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ng1421","volume":"36","author":"JH Mansfield","year":"2004","unstructured":"Mansfield JH, Harfe BD, Nissen R, Obenauer J, Srineel J, Chaudhuri A et al. MicroRNA-responsive 'sensor' transgenes uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression. Nat Genet 2004; 36: 1079\u20131083.","journal-title":"Nat Genet"},{"key":"BFcgt201550_CR32","doi-asserted-by":"publisher","first-page":"18081","DOI":"10.1073\/pnas.0506216102","volume":"102","author":"N Felli","year":"2005","unstructured":"Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 2005; 102: 18081\u201318086.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201550_CR33","doi-asserted-by":"publisher","first-page":"e659","DOI":"10.1038\/cddis.2013.193","volume":"4","author":"M Karaayvaz","year":"2013","unstructured":"Karaayvaz M, Zhai H, Ju J . miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer. Cell Death Dis 2013; 4: e659.","journal-title":"Cell Death Dis"},{"key":"BFcgt201550_CR34","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1499-3872(13)60048-X","volume":"12","author":"J Zhang","year":"2013","unstructured":"Zhang J, Zhang D, Wu GQ, Feng ZY, Zhu SM . Propofol inhibits the adhesion of hepatocellular carcinoma cells by upregulating microRNA-199a and downregulating MMP-9 expression. Hepatobiliary Pancreat Dis Int 2013; 12: 305\u2013309.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"BFcgt201550_CR35","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3892\/ol.2012.742","volume":"4","author":"D Ma","year":"2012","unstructured":"Ma D, Tao X, Gao F, Fan C, Wu D . miR-224 functions as an onco-miRNA in hepatocellular carcinoma cells by activating AKT signaling. Oncol Lett 2012; 4: 483\u2013488.","journal-title":"Oncol Lett"},{"key":"BFcgt201550_CR36","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1128\/MCB.01714-12","volume":"33","author":"L Goedeke","year":"2013","unstructured":"Goedeke L, Vales-Lara FM, Fenstermaker M, Cirera-Salinas D, Chamorro-Jorganes A, Ram\u00edrez CM et al. A regulatory role for microRNA 33* in controlling lipid metabolism gene expression. Mol Cell Biol 2013; 33: 2339\u20132352.","journal-title":"Mol Cell Biol"},{"key":"BFcgt201550_CR37","doi-asserted-by":"publisher","first-page":"13748","DOI":"10.1074\/jbc.M112.381392","volume":"288","author":"C Cheng","year":"2013","unstructured":"Cheng C, Li W, Zhang Z, Yoshimura S, Hao Q, Zhang C et al. MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10). J Biol Chem 2013; 288: 13748\u201313761.","journal-title":"J Biol Chem"},{"key":"BFcgt201550_CR38","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1101\/gad.1184704","volume":"18","author":"M Kiriakidou","year":"2004","unstructured":"Kiriakidou M, Nelson PT, Kouranov A, Fitziev P, Bouyioukos C, Mourelatos Z et al. A combined computational experimental approach predicts human microRNA targets. Genes Dev 2004; 18: 1165\u20131178.","journal-title":"Genes Dev"},{"key":"BFcgt201550_CR39","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ng1536","volume":"37","author":"A Krek","year":"2005","unstructured":"Krek A . Combinatorial microRNA target predictions. Nature Genet 2005; 37: 495\u2013500.","journal-title":"Nature Genet"},{"key":"BFcgt201550_CR40","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1371\/journal.pcbi.0010013","volume":"1","author":"D Grun","year":"2005","unstructured":"Grun D, Wang Y, Langenberger D, Gunsalus KC, Rajewsky N . microRNA Target predictions across seven Drosophila species and comparison to mammalian targets. PLoS Comput Biol 2005; 1: e13.","journal-title":"PLoS Comput Biol"},{"key":"BFcgt201550_CR41","doi-asserted-by":"publisher","first-page":"R68","DOI":"10.1186\/gb-2004-5-9-r68","volume":"5","author":"EA Miska","year":"2004","unstructured":"Miska EA, Alvarez-Saavedra E, Townsend M, Yoshii A, Sestan N, Rakic P et al. Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol 2004; 5: R68.","journal-title":"Genome Biol"},{"key":"BFcgt201550_CR42","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1093\/nar\/gnh186","volume":"32","author":"Y Sun","year":"2004","unstructured":"Sun Y, Koo S, White N, Peralta E, Esau C, Dean NM et al. Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res 2004; 32: e188.","journal-title":"Nucleic Acids Res"},{"key":"BFcgt201550_CR43","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1182\/blood-2010-09-306258","volume":"118","author":"S Teichler","year":"2011","unstructured":"Teichler S, Illmer T, Roemhild J, Ovcharenko D, Stiewe T, Neubauer A . MicroRNA29a regulates the expression of the nuclear oncogene Ski. Blood 2011; 118: 1899\u20131902.","journal-title":"Blood"},{"key":"BFcgt201550_CR44","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1261\/rna.5980303","volume":"9","author":"AM Krichevsky","year":"2003","unstructured":"Krichevsky AM, King KS, Donahue CP, Khrapko K, Kosik KS . A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 2003; 9: 1274\u20131281.","journal-title":"RNA"},{"key":"BFcgt201550_CR45","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1080\/10428190290026358","volume":"43","author":"H Bruchova","year":"2002","unstructured":"Bruchova H, Borovanova T, Klamova H, Brdicka R . Gene expression profiling in chronic myeloid leukemia patients treated with hydroxyurea. Leuk Lymphoma 2002; 43: 1289\u20131295.","journal-title":"Leuk Lymphoma"}],"updated-by":[{"DOI":"10.1038\/s41417-022-00573-z","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"record-id":"41161"},{"DOI":"10.1038\/s41417-022-00573-z","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000}}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt201550.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201550","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201550.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T04:33:35Z","timestamp":1672806815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,23]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["BFcgt201550"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2015.50","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,23]]},"assertion":[{"value":"2 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41417-022-00573-z","URL":"https:\/\/doi.org\/10.1038\/s41417-022-00573-z","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}